![](https://news.europawire.eu/wp-content/uploads/2023/10/Groundbreaking-Treatment-Tezepelumab-Offers-Hope-to-Severe-Asthma-Patients-144x144.jpg)
(IN BRIEF) Researchers at the University of Leicester have developed a groundbreaking treatment for severe asthma using the monoclonal antibody tezepelumab. This monthly injection targets thymic stromal lymphopoietin (TSLP), a substance associated with inflammation in the airways of severe asthma … Read the full press release